Hyaluronic acid cues for functional endothelialization of vascular constructs

Journal of Tissue Engineering and Regenerative Medicine

Volumn 2, Issue 1, 2008, Pages 22-32

  Ibrahim, Samir ^a   Ramamurthi, Anand ^a,b  

^a Clemson University   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Endothelial cells; Glycosaminoglycans; HA; Hyaluronan; Oligomers; Vascular grafts

Indexed keywords

CHEMICAL ACTIVATION; COLLAGEN; GRAFTS; HYALURONIC ACID; MUSCULOSKELETAL SYSTEM; SCAFFOLDS (BIOLOGY); TISSUE; TISSUE REGENERATION;

'CURRENT; ENDOTHELIAL-CELLS; ENDOTHELIALIZATION; GLYCOSAMINOGLYCANS; HYALURONAN; TUBE FORMATION; VASCULAR CONSTRUCT; VASCULAR GRAFTS; VASCULAR IMPLANTS;

ENDOTHELIAL CELLS;

HYALURONIC ACID; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1; BIOLOGICAL MARKER; CELL ADHESION MOLECULE; CYTOKINE; SIGNAL PEPTIDE;

ANGIOGENESIS; ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CELL REGENERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FLOW CYTOMETRY; GENE EXPRESSION; HOMEOSTASIS; IMPLANT; MATERIAL STATE; PHENOTYPE; PRIORITY JOURNAL; THROMBOCYTE ADHESION; TISSUE ENGINEERING; VASCULAR IMPLANT; ANIMAL; BLOOD CLOTTING; CELL CULTURE; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECT; METABOLISM; METHODOLOGY; PATHOLOGY; RAT; SCANNING ELECTRON MICROSCOPY; SECRETION; THROMBOSIS; VASCULAR ENDOTHELIUM;

ANIMALS; BIOLOGICAL MARKERS; BLOOD COAGULATION; CELL ADHESION MOLECULES; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; ENDOTHELIUM, VASCULAR; HYALURONIC ACID; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICROSCOPY, ELECTRON, SCANNING; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; THROMBOSIS;

EID: 53149124461     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.61     Document Type: Article

References (50)

1. Alberti S, Fornaro M. 1990; Higher transfection efficiency of genomic DNA purified with a guanidinium thiocyanate-based procedure. Nucleic Acids Res 18: 351-353.
2. Al'Qteishat A, Gaffney J, Krupinski J, et al. 2006; Changes in hyaluronan production andmetabolism following ischaemic stroke in man. Brain 129: 2158-2176.
3. Amarnath LP, Srinivas A, Ramamurthi A. 2006; In vitro hemocompatibility testing of UV-modified hyaluronan hydrogels. Biomaterials 27: 1416-1424.
4. Aruffo A, Stamenkovic I, Melnick M, et al. 1990; CD44 is the principal cell surface receptor for hyaluronate Cell 61: 1303-1313.
5. Baier Leach J, Bivens KA, et al. 2003; Photocrosslinked hyaluronic acid hydrogels: natural, biodegradable tissue engineering scaffolds. Biotechnol Bioeng 82: 578-589.
6. Bandman O, Coleman RT, Loring JF, et al. 2002; Complexity of inflammatory responses in endothelial cells and vascular smooth muscle cells determined by microarray analysis. Ann NY Acad Sci 975: 77-90.
7. Calabro A, Benavides M, Tammi M, et al. 2000; Microanalysis of enzyme digests of hyaluronan and chondroitin/dermatan sulfate by fluorophore-assisted carbohydrate electrophoresis (FACE). Glycobiology 10: 273-281.
8. Chen WY, Abatangelo G. 1999; Functions of hyaluronan in wound repair. Wound Repair Regen 7: 79-89.
9. Chirco R, Liu XW, Jung KK, et al. 2006; Novel functions of TIMPs in cell signalling. Cancer Metastasis Rev 25: 99-113.
10. Deed R, Rooney P, Kumar P, et al. 1997; Early-response gene signalling is induced by angiogenic oligosaccharides of hyaluronan in endothelial cells. Inhibition by non-angiogenic, high-molecular-weight hyaluronan. Int J Cancer 71: 251-256.
11. Dolle JP, Rezvan A, Allen FD, et al. 2005; Nerve growth factor-induced migration of endothelial cells. J Pharmacol Exp Ther 315: 1220-1227.
12. Esmon CT. 1989; The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 264: 4743-4746.
13. Gao F, Cao M, Yang C, et al. 2006; Preparation and characterization of hyaluronan oligosaccharides for angiogenesis study. J Biomed Mater Res B Appl Biomater 78: 385-392.
14. Gasson JC. 1991; Molecular physiology of granulocyte-macrophage colony-stimulating factor. Blood 77: 1131-1145.
15. Ibrahim S, Joddar B, Craps M, et al. 2007; A surface-tethered model to assess size-specific effects of hyaluronan (HA) on endothelial cells. Biomaterials 28: 825-835.
16. Imaizumi T, Albertine KH, Jicha DL, et al. 1997; Human endothelial cells synthesize ENA-78: relationship to IL-8 and to signalling of PMN adhesion. Am J Resp Cell Mol Biol 17: 181-192.
17. Jiang H, Movsesyan V, Fink DW Jr, et al. 1997; Expression of human p140trk receptors in p140trk-deficient, PC12/endothelial cells results in nerve growth factor-induced signal transduction and DNA synthesis. J Cell Biochem 66: 229-244.
18. Kasama T, Strieter RM, Lukacs NW, et al. 1995; Interferon gamma modulates the expression of neutrophil-derived chemokines. J Invest Med 43: 58-67.
19. Knudson CB, Knudson W. 2004; Hyaluronan and CD44: modulators of chondrocyte metabolism. Clin Orthop Relat Res 427S: S152-162.
20. Labarca C, Paigen K. 1980; A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 102: 344-352.
21. L'Heureux N, Paquet S, Labbe R, et al. 1998; A completely biological tissue-engineered human blood vessel. FASEB J 12: 47-56.
22. Liu D, Liu T, Li R, et al. 1998; Mechanisms regulating the binding activity of CD44 to hyaluronic acid. Front Biosci 3: d631-636.
23. McDonald JA, Camenisch TD. 2002; Hyaluronan: genetic insights into the complex biology of a simple polysaccharide. Glycoconj J 19: 331-339.
24. McKee CM, Penno MB, Cowman M, et al. 1996; Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J Clin Invest 98: 2403-2413.
25. Moncada S, Higgs EA. 2006; Nitric oxide and the vascular endothelium. In: The Vascular Endothelium (S. Moncada,A. Higgs, Eds.) Series Handbook of Experimental Pharmacology, v176/I, Chapter 7, Berlin-Heidelberg, Springer-Verlag, pp 213-254 2006.
26. Moore KL, Andreoli SP, Esmon NL, et al. 1987; Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J Clin Invest 79: 124-130.
27. Morra M. 2005; Engineering of biomaterials surfaces by hyaluronan. Biomacromolecules 6: 1205-1223.
28. Mummert ME. 2005; Immunologic roles of hyaluronan. Immunol Res 31: 189-206.
29. Murai T, Miyazaki Y, Nishinakamura H, et al. 2004; Engagement of CD44 promotes Rac activation and CD44 cleavage during tumor cell migration. J Biol Chem 279: 4541-4550.
30. Murphy JF, Lennon F, Steele C, et al. 2005; Engagement of CD44 modulates cyclooxygenase induction, VEGF generation, and proliferation in human vascular endothelial cells. FASEB J 19: 446-448.
31. Price RD, Myers S, Leigh IM, et al. 2005; The role of hyaluronic acid in wound healing: assessment of clinical evidence. Am J Clin Dermatol 6: 393-402.
32. Pries AR, Kubler WM. Normal Endothelium. In: The Vascular Endothelium (S. Moncada, A. Higgs, Eds.) Series Handbook of Experimental Pharmacology, v176/I, Chapter 1, Berlin-Heidelberg, Springer-Verlag, pp 1-40 2006.
33. Pure E, Cuff CA. 2001; A crucial role for CD44 in inflammation. Trends Mol Med 7: 213-221.
34. Ratcliffe A. 2000; Tissue engineering of vascular grafts. Matrix Biol 19: 353-357.
35. Rollins BJ. 1997; Chemokines. Blood 90: 909-928.
36. Rossler A, Hinghofer-Szalkay H. 2003; Hyaluronan fragments: an information-carrying system? Horm Metab Res 35: 67-68.
37. Sattar A, Rooney P, Kumar S, et al. 1994; Application of angiogenic oligosaccharides of hyaluronan increases blood vessel numbers in rat skin. J Invest Dermatol 103: 576-579.
38. Siegel-Axel DI, Gawaz M. 2007; Platelets and endothelial cells. Semin Thromb Hemost 33: 128-135.
39. Siegelman MH, DeGrendele HC, Estess P. 1999; Activation and interaction of CD44 and hyaluronan in immunological systems. J Leukoc Biol 66: 315-321.
40. Slevin M, Krupinski J, Gaffney J, et al. 2006; Hyaluronan-mediated angiogenesis in vascular disease: Uncovering RHAMM and CD44 receptor signalling pathways. Matrix Biol 26: 58-68.
41. Solymoss S, Tucker MM, Tracy PB. 1988; Kinetics of inactivation of membrane-bound factor Va by activated protein C. Protein S modulates factor Xa protection. J Biol Chem 263: 14884-14890.
42. Spicer AP, Tien JY. 2004; Hyaluronan and morphogenesis. Birth Defects Res C Embryo Today 72: 89-108.
43. Taylor KR, Trowbridge JM, Rudisill JA, et al. 2004; Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J Biol Chem 279: 17079-17084.
44. Termeer C, Benedix F, Sleeman J, et al. 2002; Oligosaccharides of hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 195: 99-111.
45. Toole BP, Wight TN, Tammi MI. 2002; Hyaluronan-cell interactions in cancer and vascular disease. J Biol Chem 277: 4593-4596.
46. Umehara H, Bloom ET, Okazaki T, et al. 2004; Fractalkine in vascular biology: from basic research to clinical disease. Arterioscler Thromb Vasc Biol 24: 34-40.
47. Vercruysse KP, Prestwich GD. 1998; Hyaluronate derivatives in drug delivery. Crit Rev Ther Drug Carrier Syst 15: 513-555.
48. West DC, Kumar S. 1989; The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity. Exp Cell Res 183: 179-196.
49. Xue L, Greisler HP. 2003; Biomaterials in the development and future of vascular grafts. J Vasc Surg 37: 472-480.
50. Yow KH, Ingram J, Korossis SA, et al. 2006; Tissue engineering of vascular conduits. Br J Surg 93: 652-661.